Vogt, Melina
Dienstbier, Niklas http://orcid.org/0009-0000-0871-9165
Schliehe-Diecks, Julian
Scharov, Katerina
Tu, Jia-Wey
Gebing, Philip
Hogenkamp, Julian
Bilen, Berna-Selin
Furlan, Silke
Picard, Daniel http://orcid.org/0000-0003-3375-6202
Remke, Marc http://orcid.org/0000-0002-9404-9993
Yasin, Layal
Bickel, David http://orcid.org/0000-0003-0332-8338
Kalia, Munishikha
Iacoangeli, Alfredo http://orcid.org/0000-0002-5280-5017
Lenz, Thomas http://orcid.org/0000-0002-4799-5549
Stühler, Kai
Pandyra, Aleksandra A.
Hauer, Julia
Fischer, Ute http://orcid.org/0000-0002-2455-2489
Wagener, Rabea
Borkhardt, Arndt http://orcid.org/0000-0002-6121-4737
Bhatia, Sanil http://orcid.org/0000-0001-6494-7744
Article History
Received: 6 June 2023
Revised: 22 November 2023
Accepted: 23 November 2023
First Online: 6 December 2023
Competing interests
: The authors declare no competing interests.
: All animal experiments were conducted in accordance with the regulatory guidelines of the official committee at LANUV (Akt. 81-02.04.2017.A441), under the authorization of the animal research institute (ZETT) at the Heinrich Heine University Düsseldorf. In house leukemia cells derived from the peripheral blood (PB) or bone marrow (BM) of three relapsed (TKI-resistant) patients after obtaining informed consent in accordance with the Declaration of Helsinki. The experiments were approved by the ethics committee of the medical faculty of the Heinrich Heine University (Study Nr.: 2019-566).